Trump ad­min­is­tra­tion tries to lure Ger­man coro­n­avirus vac­cine mak­er to US — re­ports

The Trump ad­min­is­tra­tion is try­ing to lure Cure­Vac, one of the first com­pa­nies to en­ter the hunt for a coro­n­avirus vac­cine, away from its base in Ger­many and to the Unit­ed States, Reuters and a lead­ing Ger­man news­pa­per re­port­ed.

Cit­ing un­named Ger­man gov­ern­ment sources, the Ger­man week­ly Welt am Son­ntag re­port­ed Sun­day that the US gov­ern­ment had of­fered funds to bring Cure­Vac to the US and gain ac­cess to the vac­cine it was de­vel­op­ing, while the Ger­man gov­ern­ment was at­tempt­ing to con­vince Cure­Vac to stay and man­u­fac­ture its vac­cine in Ger­many and Eu­rope. The coun­try’s health min­istry con­firmed parts of the re­port to Reuters. 

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER